Alvotech to invests $250M in the development of biosimilar monoclonal antibodies Alvotech http://orlistatindia.com.

April 3rd, 2017 care

Alvotech to invests $250M in the development of biosimilar monoclonal antibodies Alvotech, a powerful new player in the field of biopharmaceuticals, today announced plans to invest $250 million in the development and manufacturing of a portfolio of biosimilar monoclonal antibodies http://orlistatindia.com click here . Alvotech's current biosimilar assets include follow-on versions of leading monoclonal antibodies…


Medical Director.

April 2nd, 2017 rehabilitation

The CoC has accredited near 1,500 cancer treatment centers throughout the United States, which in turn treat 70 to 80 % of most cancer patients diagnosed each year. Furthermore, we are motivated to have Geisinger’s ProvenCare model used in this study because it positions health care providers to use ‘best practices’ in treating individuals. And…


From its Phase 1 studies in the ERS Annual Congress in Barcelona.

April 1st, 2017 nutrition

The treatments led to high concentrations of ciprofloxacin in the sputum of non-CF bronchiectasis individuals. ARD-3150 supplied sustained ciprofloxacin levels similar to ARD-3100 but it also exhibited an early spike of ciprofloxacin concentration that could have additional therapeutic benefits. A double-blind, randomized, placebo-controlled Phase 2b clinical trial in BE individuals with one month treatment with…


Antares Pharma first quarter total revenues boost to $3.

April 1st, 2017 treatments

Revenue from royalties was $0.7 million and $0.4 million for the three months ended March 31, 2011 and 2010, respectively. Total gross profit increased in the initial quarter of 2011 to $2.1 million compared to $2.0 million in 2010 2010. The increase in the one fourth was primarily because of the increase in royalties. Total…